Patents by Inventor Ryan Burnett

Ryan Burnett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of friedreich's ataxia using histone deacetylase inhibitors
    Patent number: 9957225
    Abstract: The invention provides methods of treating Friedreich's ataxia and other neurodegenerative or neuromuscular conditions using histone deacetylase inhibitors.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: May 1, 2018
    Assignee: The Scripps Research Institute
    Inventors: Joel M. Gottesfeld, Ann-Kristin Jenssen, David M. Herman, Ryan Burnett, C. James Chou
  • TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS
    Publication number: 20150080472
    Abstract: The invention provides methods of treating Friedreich's ataxia using histone deacetylase inhibitors.
    Type: Application
    Filed: September 9, 2014
    Publication date: March 19, 2015
    Inventors: JOEL M. GOTTESFELD, ANN-KRISTIN JENSSEN, DAVID M. HERMAN, RYAN BURNETT, C. JAMES CHOU
  • Treatment of friedreich's ataxia using histone deacetylase inhibitors
    Patent number: 8835502
    Abstract: The invention provides methods of treating Friedreich's ataxia using histone deacetylase inhibitors.
    Type: Grant
    Filed: April 15, 2013
    Date of Patent: September 16, 2014
    Assignee: The Scripps Research Institute
    Inventors: Joel M. Gottesfeld, Kai Jenssen, David M. Herman, Ryan Burnett, C. James Chou
  • TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS
    Publication number: 20130210918
    Abstract: The invention provides methods of treating Friedreich's ataxia using histone deacetylase inhibitors.
    Type: Application
    Filed: April 15, 2013
    Publication date: August 15, 2013
    Applicant: The Scripps Research Institute
    Inventors: Joel M. Gottesfeld, Kai Jenssen, David M. Herman, Ryan Burnett, C. James Chou
  • TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS
    Publication number: 20110021562
    Abstract: The invention provides methods of treating Friedreich's ataxia using histone deacetylase inhibitors.
    Type: Application
    Filed: May 4, 2010
    Publication date: January 27, 2011
    Applicant: THE SCRIPPS RESEARCH INSTUTE
    Inventors: KAI JENSSEN, DAVID M. HERMAN, JOEL M. GOTTESFELD, RYAN BURNETT, C. JAMES CHOU
  • Histone deacetylase inhibitors as therapeutics for neurological diseases
    Publication number: 20070219244
    Abstract: The invention provides HDAC inhibitors that may be used as therapeutics for the treatment of a neurodegenerative or neuromuscular condition. The invention provides compounds of formula I: The invention also provides pharmaceutical compositions and articles of manufacture that include these compounds, as well as methods of treating and methods of preventing or delaying the onset of a neurodegenerative or neuromuscular condition.
    Type: Application
    Filed: November 10, 2006
    Publication date: September 20, 2007
    Applicant: The Scripps Research Institute
    Inventors: Kai Jenssen, David Herman, Joel Gottesfeld, Ryan Burnett, C. Chou
  • Small molecule therapeutics and uses therefor
    Publication number: 20060270727
    Abstract: The invention provides polyamides which bind genes having expanded oligonucleotide repeat sequences, which binding modulates transcription. The invention further provides methods of modulation of the transcription of such genes, and the use of polyamides as therapeutic agents to treat diseases associated with such genes.
    Type: Application
    Filed: May 2, 2006
    Publication date: November 30, 2006
    Inventors: Christian Melander, Ryan Burnett, Peter Dervan, Joel Gottesfeld
  • Methods of treating cancer by inhibiting histone gene expression
    Publication number: 20060019972
    Abstract: Methods are provided for decreasing the rate or inhibiting neoplastic cell proliferation by reducing or inhibiting histone H4 gene expression or histone H4 activity. Also provided are methods of treating a patient with a neoplastic disease, and compositions useful for treating a cancer patient, including, for example, a composition containing small interfering RNA molecules that reduce or inhibit histone H4 expression in a cell or a composition containing a pyrrole-imidazole polyamide operatively linked to a chemotherapeutic molecule.
    Type: Application
    Filed: April 27, 2005
    Publication date: January 26, 2006
    Inventors: Peter Dervan, Liliane Dickinson, Paramjit Arora, Ryan Burnett, Joel Gottesfeld